What is Avalo Therapeutics's deferred taxes?

Avalo Therapeutics (AVTX) reported deferred taxes of $12K in Q1 2026.

How has Avalo Therapeutics's deferred taxes changed year-over-year?

Avalo Therapeutics's deferred taxes increased by 50.0% year-over-year, from $8K to $12K.

What is the long-term trend for Avalo Therapeutics's deferred taxes?

Over 3 years (2021 to 2025), Avalo Therapeutics's deferred taxes has grown at a 95.7% compound annual growth rate (CAGR), from -$22K to $165K.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Avalo Therapeutics AVTX Deferred Taxes

Deferred Taxes at other companies

Eli LillyLLY

$1.48B+277%

AbbVieABBV

$137M+589%

AnaptysBio, Inc.ANAB

$0+100%

Aurinia PharmaceuticalsAUPH

$9.28M—

Kiniksa Pharmaceuticals International, plcKNSA

$4.52M+51.1%

TG TherapeuticsTGTX

$3.86M—

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's deferred taxes?: Avalo Therapeutics (AVTX) reported deferred taxes of $12K in Q1 2026.
How has Avalo Therapeutics's deferred taxes changed year-over-year?: Avalo Therapeutics's deferred taxes increased by 50.0% year-over-year, from $8K to $12K.
What is the long-term trend for Avalo Therapeutics's deferred taxes?: Over 3 years (2021 to 2025), Avalo Therapeutics's deferred taxes has grown at a 95.7% compound annual growth rate (CAGR), from -$22K to $165K.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.